
Supplements and Featured Publications
- Prescription Drug Copays and Their Effect on Vulnerable Populations
- Volume 12
- Issue 13 Suppl
Participating Faculty
Prescription Drug Copays and Their Effect on Vulnerable Populations
This supplement to
The American Journal of Managed Care
is based on a closed-panel roundtable meeting held in Philadelphia, Pennsylvania, on June 13, 2006, in which 5 experts in various fields discussed prescription drug copays and their effect on vulnerable populations.
Faculty
Michael E. Chernew, PhDProfessor of Healthcare Policy
Boston, Massachusetts
William Fleming, PharmDVice President, Pharmacy and Clinical Integration
Louisville, Kentucky
John J. Mahoney, MDCorporate Medical Director
Stamford, Connecticut
David Nash, MD, MBADr. Raymond C. and Doris N. Grandon Professorof Health PolicyChairman, Department of Health Policy
Philadelphia, Pennsylvania
Richard C. Surles, PhDExecutive Vice President
Pennington, New Jersey
Articles in this issue
almost 19 years ago
Impact of Copays in Vulnerable Populationsalmost 19 years ago
Vulnerable Populations: Who Are They?almost 19 years ago
Benefit-based Copays in the Real World: The Employer PerspectiveNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.